Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma
CompletedOBSERVATIONAL
Enrollment
12
Participants
Timeline
Start Date
September 30, 2014
Primary Completion Date
January 31, 2015
Study Completion Date
April 22, 2018
Conditions
Melanoma
Trial Locations (1)
M5G 2M9
Princess Margaret Cancer Centre, Toronto
All Listed Sponsors
lead
University Health Network, Toronto
OTHER
NCT02251314 - Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma | Biotech Hunter | Biotech Hunter